Carnosine

From NuGOwiki

(Redirected from HMDB00033)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

Carnosine
2D structure for Carnosine
Chemical Name (2S)-2-(3-aminopropanoylamino)-3-(3H-imidazol-4-yl)propanoic acid
Chemical Formula C9H14N4O3
CAS Number 305-84-0
Chemical Information HMDB00033
Biochemical Taxonomy

  • Peptides

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways

  • Beta-Alanine Metabolism

Biofluid Location

  • Blood
  • Urine

Tissue Location

  • Fibroblasts
  • Intestine
  • Kidney
  • Liver
  • Muscle
  • Neurons
  • Skeletal Muscle
  • Brain

Normal Biofluid Concentrations

  • Blood: 3.1 +/- 7.5 uM
  • Blood: 6.54 +/- 1.0 umol/L
  • Urine: 0.014-0.032 umol/mmol creatinine
  • Urine: 1.1+/-0.5 umol/mmol creatinine
  • Urine: 3.2 +/- 4.36 umol/mmol creatinine
  • Urine: 3.5 +/- 2.7 umol/mmol creatinine
  • Urine: 4.0 +/- 2.5 umol/mmol creatinine
  • Urine: <6.579 umol/mmol creatinine

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Carnosinuria
  • Probable Alzheimer's Disease

Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations

  • Blood (Probable Alzheimer's Disease): 3.28 +/- 0.91 uM
  • Urine (Carnosinuria): 56.56-113.1 umol/mmol creatinine

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
Carnosine (beta-alanyl-L-histidine) is found exclusively in animal tissues. Carnosine has the potential to suppress many of the biochemical changes (e.g., protein oxidation, glycation, AGE formation, and cross-linking) that accompany aging and associated pathologies. (PMID 16804013) Carnosine is a dipeptide of the amino acids beta-alanine and histidine. It is highly concentrated in muscle and brain tissues. Some autistics patients take it as a dietary supplement, and attribute an improvement in their condition to it. Supplemental carnosine may increase corticosterone levels. This may explain the "hyperactivity" seen in autistic subjects at higher doses. Carnosine also exhibits some anti-oxidant effects.

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Carnosinuria
  • Probable Alzheimer's Disease

Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines